Trials / Completed
CompletedNCT03998449
Immunogenicity of Cholera Vaccine in Children With IBD
Evaluation of Immunogenicity of Cholera Vaccine in Children With Inflammatory Bowel Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of the immunogenicity and safety of immunization against cholera in children with inflammatory bowel disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Vaccination against cholera | Participants will receive two doses of an oral cholera vaccine with an interval of 2-4 weeks. |
Timeline
- Start date
- 2017-08-30
- Primary completion
- 2020-04-01
- Completion
- 2020-05-01
- First posted
- 2019-06-26
- Last updated
- 2020-05-20
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03998449. Inclusion in this directory is not an endorsement.